Bristol-Myers Squibb Co. (BMY) Sotyktu Label Better-than-Expected - Cowen
Tweet Send to a Friend
Cowen analyst Steve Scala reiterated an Outperform rating and $85.00 price target on Bristol-Myers Squibb Co. (NYSE: BMY) after Sotyktu ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
